AAIM
PCRX icon

American Assets Investment Management’s Pacira BioSciences PCRX Stock Holding History

American Assets Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,000
Closed -$466K – 182
2018
Q2 		$466K Hold
15,000
– – 0.08% 159
2018
Q1 		$467K Buy
+15,000
New +$534K 0.09% 154

Other funds holding PCRX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

American Assets Investment Management's PCRX Position: Q3 2018 in Review

American Assets Investment Management sold out of Pacira BioSciences (PCRX) in Q3 2018, closing a stake of 15,000 shares — an estimated $466K sold.

American Assets Investment Management first reported a position in PCRX in Q1 2018 and held it in 2 quarters. The position peaked at $467K in Q1 2018. 187 funds tracked by Wall St. Rank hold PCRX as of Q3 2018.

  • American Assets Investment Management reported no remaining Pacira BioSciences position as of Q3 2018 after selling out during the quarter.
  • American Assets Investment Management sold 15,000 Pacira BioSciences shares in Q3 2018, an estimated $466K.
  • American Assets Investment Management first reported a position in Pacira BioSciences in Q1 2018 and held it in 2 quarters.
  • American Assets Investment Management's Pacira BioSciences position peaked at $467K in Q1 2018.
  • 187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2018.

Based on American Assets Investment Management's 13F filing for Q3 2018, filed 22 Oct 2018.